135 related articles for article (PubMed ID: 10380709)
21. Nucleotide sequence of the ACI rat CTLA-4 molecule.
Oaks MK; Penwell RT; Tector AJ
Immunogenetics; 1996; 43(3):173-4. PubMed ID: 8550107
[No Abstract] [Full Text] [Related]
22. Short cytoplasmic SDYMNM segment of CD28 is sufficient to convert CTLA-4 to a positive signaling receptor.
Yin L; Schneider H; Rudd CE
J Leukoc Biol; 2003 Jan; 73(1):178-82. PubMed ID: 12525576
[TBL] [Abstract][Full Text] [Related]
23. CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis.
Djilali-Saiah I; Ouellette P; Caillat-Zucman S; Debray D; Kohn JI; Alvarez F
Hum Immunol; 2001 Dec; 62(12):1356-62. PubMed ID: 11756004
[TBL] [Abstract][Full Text] [Related]
24. A recently described polymorphism in the CD28 gene on chromosome 2q33 is not associated with susceptibility to type 1 diabetes.
Wood JP; Pani MA; Bieda K; Meyer G; Usadel KH; Badenhoop K
Eur J Immunogenet; 2002 Aug; 29(4):347-9. PubMed ID: 12121283
[TBL] [Abstract][Full Text] [Related]
25. CD28, CTLA-4 and their ligands: who does what and to whom?
Sansom DM
Immunology; 2000 Oct; 101(2):169-77. PubMed ID: 11012769
[No Abstract] [Full Text] [Related]
26. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
[TBL] [Abstract][Full Text] [Related]
27. Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation.
Li D; Gál I; Vermes C; Alegre ML; Chong AS; Chen L; Shao Q; Adarichev V; Xu X; Koreny T; Mikecz K; Finnegan A; Glant TT; Zhang J
J Immunol; 2004 Dec; 173(12):7135-9. PubMed ID: 15585834
[TBL] [Abstract][Full Text] [Related]
28. Molecular linkage of the human CTLA4 and CD28 Ig-superfamily genes in yeast artificial chromosomes.
Buonavista N; Balzano C; Pontarotti P; Le Paslier D; Golstein P
Genomics; 1992 Jul; 13(3):856-61. PubMed ID: 1322357
[TBL] [Abstract][Full Text] [Related]
29. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel MF; Allison JP
J Exp Med; 1995 Aug; 182(2):459-65. PubMed ID: 7543139
[TBL] [Abstract][Full Text] [Related]
30. CTLA-4--the costimulatory molecule that doesn't: regulation of T-cell responses by inhibition.
Chambers CA; Allison JP
Cold Spring Harb Symp Quant Biol; 1999; 64():303-12. PubMed ID: 11232300
[No Abstract] [Full Text] [Related]
31. CTLA-4 and CD28: similar proteins, neighbouring genes.
Balzano C; Buonavista N; Rouvier E; Golstein P
Int J Cancer Suppl; 1992; 7():28-32. PubMed ID: 1330947
[TBL] [Abstract][Full Text] [Related]
32. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
33. Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease.
Popat S; Hearle N; Hogberg L; Braegger CP; O'Donoghue D; Falth-Magnusson K; Holmes GK; Howdle PD; Jenkins H; Johnston S; Kennedy NP; Kumar PJ; Logan RF; Marsh MN; Mulder CJ; Torinsson Naluai A; Sjoberg K; Stenhammar L; Walters JR; Jewell DP; Houlston RS
Ann Hum Genet; 2002 Mar; 66(Pt 2):125-37. PubMed ID: 12174216
[TBL] [Abstract][Full Text] [Related]
34. Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence.
Wang XB; Kakoulidou M; Giscombe R; Qiu Q; Huang D; Pirskanen R; Lefvert AK
J Neuroimmunol; 2002 Sep; 130(1-2):224-32. PubMed ID: 12225905
[TBL] [Abstract][Full Text] [Related]
35. B70 antigen is a second ligand for CTLA-4 and CD28.
Azuma M; Ito D; Yagita H; Okumura K; Phillips JH; Lanier LL; Somoza C
Nature; 1993 Nov; 366(6450):76-9. PubMed ID: 7694153
[TBL] [Abstract][Full Text] [Related]
36. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location.
Harper K; Balzano C; Rouvier E; Mattéi MG; Luciani MF; Golstein P
J Immunol; 1991 Aug; 147(3):1037-44. PubMed ID: 1713603
[TBL] [Abstract][Full Text] [Related]
37. CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study.
Holopainen P; Arvas M; Sistonen P; Mustalahti K; Collin P; Mäki M; Partanen J
Tissue Antigens; 1999 May; 53(5):470-5. PubMed ID: 10372542
[TBL] [Abstract][Full Text] [Related]
38. Established T cell-driven germinal center B cell proliferation is independent of CD28 signaling but is tightly regulated through CTLA-4.
Walker LS; Wiggett HE; Gaspal FM; Raykundalia CR; Goodall MD; Toellner KM; Lane PJ
J Immunol; 2003 Jan; 170(1):91-8. PubMed ID: 12496387
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.
Guo Y; Wu Y; Zhao M; Kong XP; Liu Y
J Exp Med; 1995 Apr; 181(4):1345-55. PubMed ID: 7535334
[TBL] [Abstract][Full Text] [Related]
40. Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis.
Huang D; Giscombe R; Zhou Y; Pirskanen R; Lefvert AK
J Neuroimmunol; 2000 Jun; 105(1):69-77. PubMed ID: 10713366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
